The preparation of deuterium labeled fexinidazole, a 5‐nitroimidazole drug candidate for the treatment of Human African Trypanosomiasis, and its two main metabolites (fexinidazole sulfoxide and fexinidazole sulfone) for use as internal standards for liquid chromatography‐mass spectrometry are report
Syntheses of [2H3, 15N], [14C]Nexavar™ and its labeled metabolites
✍ Scribed by U. Pleiss; M. Gerisch; D. Seidel
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- French
- Weight
- 150 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Nexavar TM , Sorafenib tosylate (BAY 43-9006 tosylate) is a potent small molecule Raf kinase inhibitor for the treatment of hyperproliferative disorders such as cancer. Both radiolabeled and stable isotope labeled compounds were required for drug absorption, distribution, metabolism and excretion (ADME) and quantitative mass spectrometry bio-analytical studies. Nexavar TM labeled with carbon-14 in the carboxamide group was prepared in two steps in an overall radiochemical yield of 42% starting from 4-chloro-N-methyl-2-pyridine-[ 14 C]carboxamide. The [ 2 H 3 , 15 N] version of Nexavar TM was prepared in 75% yield based on 4-chloro-N-[ 2 H 3 ]methyl-2-pyridine-[ 15 N]carboxamide. The pyridine N-oxide metabolite labeled with carbon-14 as well as with deuterium and nitrogen-15 and was synthesized by oxidation in yields of 59% and 87%, respectively. Starting from [ 2 H 2 , 13 C]formaldehyde the N-hydroxymethyl metabolite was labeled with carbon-13 and deuterium in one step in a 45% overall yield.
📜 SIMILAR VOLUMES
## Abstract Tritium and ^14^C‐labeled isomers of ethyl acetate are excellent substrates for competitive dual‐labeled radioactive isotopic measurements of β‐deuterium and β‐tritium isotope effects. Methods are given for preparation of the ethyl esters of acetic acid‐2‐^3^H, acetic acid‐2‐^14^C, and
## Abstract In support of a program to develop a treatment for depression, three isotopically labeled forms of the 5‐HT~1B~ antagonist AZ12320927 were synthesized. A tritium labeled version was synthesized for autoradiography using Ir‐catalyzed hydrogen–tritium exchange. A C‐14 labeled version was
## Abstract In support of a program to develop a treatment for chemotherapy‐induced nausea and vomiting, two isotopically labeled forms of neurokinin‐1 receptor antagonist aprepitant have been synthesized. A [^l4^C]‐labeled version was synthesized for use in metabolism studies, while a [^13^C~2~,^1
Three syntheses o f r a d i o l a b e l l e d 2-[2-(2-N.N-Dlmethylarnlnomethyl-5 -f uranyl-methyl thlo)ethylamlno]-5-( 6-hydroxy-l-plcolyl ) -4pyrlmldone t r i h y d r o c h l o r l d e (donetldlne t r i h y d r o c h l o r i d e ) are described. One descrlbes the preparatlon o f the f r e e base, a